Related Experiment Video
Updated: May 20, 2026
11:47
A Novel in vivo Gene Transfer Technique and in vitro Cell Based Assays for the Study of Bone Loss in Musculoskeletal Disorders
Published on: June 8, 2014
Statins, bone formation and osteoporosis: hope or hype?
Athanasios N Tsartsalis1, Charalambos Dokos, Georgia D Kaiafa
1Department of Diabetes and Endocrinology, Whittington Hospital, London, UK.
Hormones (Athens, Greece)
|July 18, 2012
Summary
Statins may improve bone density by promoting bone metabolism, potentially aiding osteoporosis management. Further research is needed to confirm these anabolic effects for specific statins.
Area of Science:
- Biomedical Science
- Pharmacology
- Bone Biology
Background:
- Osteoporosis is a significant global health issue impacting both genders.
- Statins, primarily used for lipid reduction, exhibit pleiotropic effects, including potential benefits for bone mineral density.
- Emerging evidence suggests a link between statins, bone metabolism, and the RANKL/OPG pathway.
Purpose of the Study:
- To investigate the anabolic effects of statins on bone metabolism.
- To explore the role of the RANKL/OPG pathway in statin-induced bone effects.
- To assess the potential of statins in managing osteoporosis and related metabolic disorders.
Main Methods:
- Review of experimental studies.
- Analysis of clinical trial data.
- Examination of existing meta-analyses.
- Investigation of the shared RANKL/OPG pathway in statins, osteoporosis, and adipogenesis.
Main Results:
- Experimental and clinical data predominantly indicate that statins exert an anabolic effect on bone metabolism.
- The RANKL/OPG pathway is implicated in the pathophysiology of osteoporosis and other metabolic conditions, and statins may influence this pathway.
- An imbalance in the RANKL/OPG pathway is associated with metabolic disorders including diabetes mellitus, atherogenesis, and multiple myeloma.
Conclusions:
- Statins demonstrate a promising anabolic effect on bone metabolism, suggesting a potential therapeutic role in osteoporosis.
- The RANKL/OPG pathway represents a key molecular target for statins in bone health and metabolic regulation.
- Future research, including large, statin-specific randomized controlled trials, is essential to validate statins as a treatment for bone disorders.
Related Concept Videos
01:20Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
01:17Hormones and Bone Tissue
The endocrine system produces and secretes hormones, which interact with the skeletal system. These hormones control bone growth, maintain bone once it is formed, and remodel it.
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
01:40Bone Remodeling
Bone remodeling is a continuous and balanced process of bone resorption by osteoclasts and bone formation by osteoblasts. In adults, it helps maintain bone mass and calcium homeostasis. While mechanical stress can stimulate turnover as part of the normal maintenance and reparative process, several hormones also regulate bone remodeling.
01:25Role of Vitamins in Maintaining Bone Health
The growth and maintenance of bone are regulated by a combination of nutritional factors, including vitamins, such as vitamin A, B12, C, D, and K.
Vitamin A
Vitamin A is involved in the process of bone remodeling. Retinoic acid, the active metabolite of Vitamin A, has nuclear receptors in osteoblasts and osteoclasts, which are involved in bone remodeling.
Vitamin B12
Vitamin B12 acts as a cofactor during the formation of osteoblast-related proteins, such as osteocalcin. Vitamin B12 plays a role...
Vitamin A
Vitamin A is involved in the process of bone remodeling. Retinoic acid, the active metabolite of Vitamin A, has nuclear receptors in osteoblasts and osteoclasts, which are involved in bone remodeling.
Vitamin B12
Vitamin B12 acts as a cofactor during the formation of osteoblast-related proteins, such as osteocalcin. Vitamin B12 plays a role...
01:31Osteoclasts in Bone Remodeling
Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during bone...
01:29Bone Disorders
Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...